JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB25950

Anti-IRF3 antibody

4

(3 Reviews)

|

(42 Publications)

Rabbit Polyclonal IRF3 antibody. Suitable for WB and reacts with Human samples. Cited in 42 publications. Immunogen corresponding to Synthetic Peptide within Human IRF3.

View Alternative Names

Interferon regulatory factor 3, IRF-3, IRF3

2 Images
Western blot - Anti-IRF3 antibody (AB25950)
  • WB

Unknown

Western blot - Anti-IRF3 antibody (AB25950)

Lane 1:

Western blot - Anti-IRF3 antibody (ab25950) at 1 µg/mL

Lane 2:

Western blot - Anti-IRF3 antibody (ab25950) at 2 µg/mL

Lane 3:

Western blot - Anti-IRF3 antibody (ab25950) at 4 µg/mL

All lanes:

Ramos whole cell lysate.

Predicted band size: 47 kDa

Observed band size: ~44 kDa

false

Western blot - Anti-IRF3 antibody (AB25950)
  • WB

AbReview58058****

Western blot - Anti-IRF3 antibody (AB25950)

Samples were incubated with primary antibody for 18 hours at 4°C and blocked with 5% BSA for 1 hour at room temperature.

All lanes:

Western blot - Anti-IRF3 antibody (ab25950) at 1/1000 dilution

All lanes:

HT-29 at 30 µg

Secondary

All lanes:

HRP conjugated Anti-rabbit IgG, Goat polyclonal at 1/1000 dilution

Predicted band size: 47 kDa

true

This image is courtesy of an anonymous Abreview

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human IRF3. The exact immunogen used to generate this antibody is proprietary information.

Q14653

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
IRF3 Antibody is affinity chromatography purified via peptide column.
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IRF3 also known as Interferon Regulatory Factor 3 acts as an important transcription factor in the immune response. It has a molecular weight of approximately 47 kDa. The IRF3 protein is mainly expressed in the cytoplasm and nucleus of various cell types including immune cells such as macrophages and dendritic cells. The protein becomes activated through phosphorylation a process frequently identified in its phosphorylated form phospo-IRF3 or p-IRF3 which facilitates its role in immune function.
Biological function summary

IRF3 participates in the regulation of type I interferon (IFN) response a fundamental antiviral defense mechanism. IRF3 when phosphorylated forms a complex with CBP/p300 which then translocates to the nucleus to drive the expression of IFN-stimulated genes. This action strengthens the innate immune response and boosts the body's ability to counteract viral infections. Its activity and regulation are significant for maintaining a balanced immune response without excessive inflammation.

Pathways

IRF3 is involved in the Toll-like receptor (TLR) and RIG-I-like receptor (RLR) signaling pathways both essential in pathogen recognition and response. Within these pathways IRF3 interacts with proteins such as MAVS and TBK1 to propagate immune signaling. The activation of IRF3 in these pathways results in the production of type I interferons and other cytokines orchestrating an effective antiviral response. These interactions highlight the protein's central role in mediating immune signaling cascades.

IRF3's malfunction or deregulation can contribute to autoimmune diseases and antiviral deficiencies. Conditions such as systemic lupus erythematosus (SLE) and chronic hepatitis B infection are linked to IRF3 activity. During autoimmune responses or viral persistence the aberrant activation of IRF3 can lead to inappropriate immune responses. The connection with proteins like STAT1 in these conditions highlights the complex network IRF3 engages in facilitating its impact on disease progression and immune dysregulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Key transcriptional regulator of type I interferon (IFN)-dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses (PubMed : 22394562, PubMed : 24049179, PubMed : 25636800, PubMed : 27302953, PubMed : 31340999, PubMed : 36603579, PubMed : 8524823, PubMed : 39362857). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (PubMed : 11846977, PubMed : 16846591, PubMed : 16979567, PubMed : 20049431, PubMed : 32972995, PubMed : 36603579, PubMed : 8524823). Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction (PubMed : 16846591, PubMed : 16979567, PubMed : 20049431, PubMed : 36603579). Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, is phosphorylated by IKBKE and TBK1 kinases (PubMed : 22394562, PubMed : 25636800, PubMed : 27302953, PubMed : 36603579). This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes (PubMed : 16154084, PubMed : 27302953, PubMed : 33440148, PubMed : 36603579). Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages (PubMed : 16846591). In response to Sendai virus infection, is recruited by TOMM70 : HSP90AA1 to mitochondrion and forms an apoptosis complex TOMM70 : HSP90AA1 : IRF3 : BAX inducing apoptosis (PubMed : 25609812). Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed : 33440148).
See full target information IRF3

Publications (42)

Recent publications for all applications. Explore the full list and refine your search

PLoS pathogens 21:e1013443 PubMed40875754

2025

The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses.

Applications

Unspecified application

Species

Unspecified reactive species

Jelle G Schipper,Chiara Aloise,Sereina O Sutter,Marleen Zwaagstra,Arno L W van Vliet,Rana Abdelnabi,Bob Ignacio,Kimberly M Bonger,Dagmar Roelofs,Judith M A van den Brand,Richard W Wubbolts,Lucas J M Bruurs,Hendrik Jan Thibaut,Johan Neyts,Marvin E Tanenbaum,Frank J M van Kuppeveld

Bioactive materials 24:37-53 PubMed36582350

2022

Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Haotian Shen,Lulu Jin,Qiangqiang Zheng,Ziqiang Ye,Linxiang Cheng,Yuxu Wu,Honghao Wu,Tae Gyong Jon,Wenduo Liu,Zongyou Pan,Zhengwei Mao,Yue Wang

Frontiers in immunology 13:1020262 PubMed36248821

2022

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway degradation of RIG-I and MDA5.

Applications

Unspecified application

Species

Unspecified reactive species

Asela Weerawardhana,Md Bashir Uddin,Joo-Hyung Choi,Prabuddha Pathinayake,Sung Ho Shin,Kiramage Chathuranga,Jong-Hyeon Park,Jong-Soo Lee

Cell death & disease 13:640 PubMed35869062

2022

Mitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Gaolei Hu,Yalan Chen,Xinyu Yang,Yang Wang,Jianli He,Tianshi Wang,Qiuju Fan,Liufu Deng,Jun Tu,Hongsheng Tan,Jinke Cheng

Journal of virology 96:e0102222 PubMed35861515

2022

African Swine Fever Virus EP364R and C129R Target Cyclic GMP-AMP To Inhibit the cGAS-STING Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Niranjan Dodantenna,Lakmal Ranathunga,W A Gayan Chathuranga,Asela Weerawardhana,Ji-Won Cha,Ashan Subasinghe,Nuwan Gamage,D K Haluwana,YongKwan Kim,WeonHwa Jheong,Haryoung Poo,Jong-Soo Lee

Cell cycle (Georgetown, Tex.) 21:767-779 PubMed35130108

2022

STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Mingming Yin,Jinlong Hu,Zhongxu Yuan,Guangyi Luo,Jiaming Yao,Rundong Wang,Dongquan Liu,Baoqiang Cao,Wenyong Wu,Zhiqi Hu

PLoS pathogens 17:e1010142 PubMed34929018

2021

Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus.

Applications

Unspecified application

Species

Unspecified reactive species

Miaoge Xue,Yuexiu Zhang,Haitao Wang,Elizabeth L Kairis,Mijia Lu,Sadeem Ahmad,Zayed Attia,Olivia Harder,Zijie Zhang,Jiangbo Wei,Phylip Chen,Youling Gao,Mark E Peeples,Amit Sharma,Prosper Boyaka,Chuan He,Sun Hur,Stefan Niewiesk,Jianrong Li

Journal of virology 95: PubMed33536170

2021

Nonsegmented Negative-Sense RNA Viruses Utilize -Methyladenosine (mA) as a Common Strategy To Evade Host Innate Immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Mijia Lu,Miaoge Xue,Hai-Tao Wang,Elizabeth L Kairis,Sadeem Ahmad,Jiangbo Wei,Zijie Zhang,Qinzhe Liu,Yuexiu Zhang,Youling Gao,Dominique Garcin,Mark E Peeples,Amit Sharma,Sun Hur,Chuan He,Jianrong Li

Open medicine (Warsaw, Poland) 16:581-590 PubMed33869780

2021

Knockdown of lncRNA TapSAKI alleviates LPS-induced injury in HK-2 cells through the miR-205/IRF3 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoning Han,Zhiyong Yuan,Yajun Jing,Weigui Zhou,Yunbo Sun,Jinyan Xing

Frontiers in veterinary science 7:570593 PubMed33240950

2020

Effects of Probiotics BaSC06 on Intestinal Digestion and Absorption, Antioxidant Capacity, Microbiota Composition, and Macrophage Polarization in Pigs for Fattening.

Applications

Unspecified application

Species

Unspecified reactive species

Xuefang Cao,Li Tang,Zihan Zeng,Baikui Wang,Yuanhao Zhou,Qi Wang,Peng Zou,Weifen Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com